Q-Line Biotech Limited · NSE · INE1G2W01011 · 78 sessions on record
₹661.10▼ −19.90 · −2.9%from ₹681.00 the session before · 1 Oct 2026 close · NSE end of day
Open
₹689.75
High
₹689.75
Low
₹640.65
Day's range
₹497.2% of the previous close
VWAP
₹660.29close +0.12% from it
Volume, shares
70,0000.64× the 20-session average
Turnover, ₹ crore
4.6
Trades
170410 shares per trade
Previous close
₹681.00−19.90 to the close
Price band, next session
₹595.00 – ₹727.2010% either side of the close · dynamic, widened in 5% steps when hit
Day range42% of the way up
₹640.65₹689.75
52-week range70% of the way up
₹487.00 24 Jul₹735.00 15 Sept
−10% from the high · +36% from the low
Futures and options
No derivatives listed on QLINE
Close ₹ · Nifty 50 rebased to the first close · futures open interest by the day's build-up78 sessions to 1 Oct · axis fixed at 4 × ATR-14 around the last close · hover or tap a session and the read beside the chart follows it
Revenue ₹342 cr; profit ₹56 cr in the Mar 2026 quarter, consolidated.
Last 1 quarters, consolidated₹ crore as filed · year on year against the same quarter a year earlier · market: close on the first session after the filing against the last close before it, Nifty 50 over the same session
Quarterly results of QLINE on the consolidated basis with the market's move on the first session after each filing
Quarter
Revenue ₹ cr
Revenue YoY
Profit ₹ cr
Profit YoY
EPS ₹
Market on the day
Mar 2026filed 17 Jun · audited
₹342 cr
—
₹56 cr
—
34.79
▲ +3.2%Nifty +0.3% · +2.8 pp
Fundamentals
consolidated · filings to Mar 2026 · close ₹661.10 on 1 Oct
Fundamentals for QLINE on the consolidated basis to Mar 2026.
Valuationarithmetic on filings and the close · each cell names what it rests on · — where an input is missing
Market cap
—no NSE market-cap record yet
Price to earnings
—fewer than four consecutive quarters filed
Trailing EPS
—fewer than four consecutive quarters filed
Price to book
—no balance sheet filed yet
Book value a share
—no equity line in the filing
Debt to equity
—no equity line in the filing
Return on equity
—needs two filed balance sheets
Dividend yield
—no dividend with an ex-date in 365 days
Face value
—no NSE record yet
Shares outstanding
—no NSE record yet
Growthsums of the four quarters filed to Mar 2026 · growth against the four quarters before them · consolidated
Revenue, trailing 12 months
—fewer than four consecutive quarters filed
Revenue growth, 12 months
—needs eight consecutive quarters filed
Revenue 3-year CAGR
—needs twelve consecutive quarters filed
Profit, trailing 12 months
—fewer than four consecutive quarters filed
Profit growth, 12 months
—needs eight consecutive quarters filed
Profit 3-year CAGR
—needs twelve consecutive quarters filed
Shareholding
quarter to 28 May · none pledged · NSE filings
Promoters hold 67.5%, foreign portfolio investors 1.7%, mutual funds 1.6% and insurance companies 0.0%, as filed for the quarter to 28 May.
67.5%16.0%
Promoters 67.5%
Foreign portfolio investors 1.7%
Mutual funds 1.6%
Insurance companies 0.0%
Banks and financial institutions 8.5%
Individual investors 16.0%
Others 4.7%
By category, last 1 quarterspercent of shares · beneath each figure, the change in percentage points against the previous quarter on file
Shareholding of QLINE by category over the last 1 quarters with the change against the previous quarter
Category
28 May
Promoters
67.51
Foreign portfolio investors
1.67
Mutual funds
1.59
Insurance companies
0.02
Banks and financial institutions
8.54
Individual investors
15.98
Bodies corporate
0.82
Others
3.87
Corporate actions
NSE and BSE records
No corporate action on record for QLINE yet.
Price history
78 sessions on record · to 1 Oct · NSE end of day
QLINE is +6.7% over 20 sessions against Nifty's −6.2%, 10% below its 52-week high, realised volatility 55% annualised.
Returns against Nifty 50longest window first · Nifty 50 over the same sessions
Returns of the stock and Nifty 50 over six windows, longest first
Window
From ₹
QLINE %
Nifty 50 %
Difference pp
60 sessionssince 8 Jul
₹539.45
▲ +23%
▼ −6.1%
+29
20 sessionssince 2 Sept
₹619.53
▲ +6.7%
▼ −6.2%
+13
5 sessionssince 24 Sept
₹674.87
▼ −2.0%
▼ −2.8%
+0.74
1 sessionsince 30 Sept
₹680.98
▼ −2.9%
▼ −0.88%
−2.0
Averages of the closeclose against each average
5-session average
₹670.00close −1.3% from it
20-session average
₹676.86close −2.3% from it
50-session average
₹592.47close +12% from it
Range and volumetrue range over 14 sessions · high to low over 20 · volume against the 20-session average
Average true range, 14
₹406.0% of the close
Average day's range, 20
₹406.0% of the close
Volume against 20 sessions
0.64×70,000 vs 1.0 L average
Volatility and co-movement with Nifty 50annualised from daily log returns · counts share one denominator per cell
Realised volatility, 20
55%≈ ±3.5% a session · moved more than that on 6 of 20
Realised volatility, 60
46%≈ ±2.9% a session · moved more than that on 14 of 60
Beta to Nifty, 60
0.95moved with Nifty on 37 of 60 sessions
Up and down sessionscloses above and below the previous close
Last 20 sessions
11 up · 9 downof 20
Last 60 sessions
28 up · 32 downof 60
Best session, 250
▲ +8.5%31 Aug
Worst session, 250
▼ −6.8%15 Sept
0 bulletins on QLINE
The desk has not written about Q-Line Biotech Limited yet. The tape carries every bulletin as it is published.
About Q-Line Biotech Limited
exchange masters as of 18 Sept 2026 · classification by BSE
Company
Q-Line Biotech Limited
Exchange
NSE
ISIN
INE1G2W01011
Sessions on record
78
Price source
NSE UDiFF bhavcopy · end of day · delayed
Filings
NSE and BSE public disclosures · results, shareholding and corporate actions as filed
Computed
1 Oct, 09:17 pm IST
Bulletins
0 · written by the desk · not a recommendation
OI Charts is not a SEBI-registered investment adviser or research analyst. Prices, open interest, filings and the desk read are exchange data and arithmetic on it, not a basis for any investment decision.